XML 49 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders' Equity
$ in Thousands
USD ($)
Share
Capital stock
USD ($)
shares
Reserves
USD ($)
Deficit
USD ($)
Beginning balance (in shares) at Dec. 31, 2022 | shares   110,664,190    
Beginning balance at Dec. 31, 2022 $ 123,201 $ 193,006 $ 11,753 $ (81,558)
Changes in equity [abstract]        
Shares issued for exercise of stock options (in shares) 1,314,000 1,314,000    
Shares issued for exercise of stock options $ 1,283 $ 2,037 (754)  
RSUs issued (in shares) | shares   255,850    
RSUs issued (198) $ 1,001 (1,199)  
Share-based payments 2,068   2,068  
Reclass of warrants to derivative liability 1,286   1,286  
Effect of functional currency change 0 $ (35,131) 8,038 27,093
Loss for the year (4,633)     (4,633)
Ending balance (in shares) at Dec. 31, 2023 | shares   112,234,040    
Ending balance at Dec. 31, 2023 $ 120,435 $ 160,913 18,620 (59,098)
Changes in equity [abstract]        
Shares issued for exercise of stock options (in shares) 1,372,000 1,372,000    
Shares issued for exercise of stock options $ 1,722 $ 2,690 (968)  
RSUs issued (in shares) | shares   164,500    
RSUs issued (122) $ 1,535 (1,657)  
Share-based payments 2,346   2,346  
Common shares returned to treasury (in shares) | shares   (3,520,208)    
Common shares returned to treasury (5,658) $ (5,658)    
Shares issued for royalty (in shares) | shares   30,000    
Shares issued for royalty 45 $ 45    
Loss for the year (3,288)     (3,288)
Ending balance (in shares) at Dec. 31, 2024 | shares   110,280,332    
Ending balance at Dec. 31, 2024 $ 115,480 $ 159,525 $ 18,341 $ (62,386)